Clearstead Advisors’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.99K Buy
+224
New +$10.6K ﹤0.01% 1974
2026
Q1
Sell
-4
Closed -$369 2545
2025
Q4
$369 Buy
+4
New +$383 ﹤0.01% 2342
2025
Q3
Sell
-183
Closed -$23.7K 3169
2025
Q2
$23.7K Sell
183
-58
-24% -$8.41K ﹤0.01% 1555
2025
Q1
$38.4K Buy
241
+5
+2% +$905 ﹤0.01% 1243
2024
Q4
$43.8K Buy
236
+17
+8% +$3.3K ﹤0.01% 1193
2024
Q3
$46.2K Hold
219
﹤0.01% 1224
2024
Q2
$29.3K Sell
219
-163
-43% -$30.8K ﹤0.01% 1289
2024
Q1
$61K Sell
382
-5
-1% -$980 ﹤0.01% 719
2023
Q4
$78.7K Sell
387
-1,347
-78% -$218K ﹤0.01% 634
2023
Q3
$344K Buy
1,734
+750
+76% +$189K 0.01% 459
2023
Q2
$319K Buy
984
+207
+27% +$59.1K 0.02% 355
2023
Q1
$182K Buy
777
+225
+41% +$56.9K 0.01% 408
2022
Q4
$139K Hold
552
0.01% 433
2022
Q3
$98K Sell
552
-96
-15% -$19.3K 0.01% 480
2022
Q2
$118K Sell
648
-287
-31% -$57.2K 0.01% 470
2022
Q1
$240K Buy
935
+225
+32% +$51.4K 0.02% 382
2021
Q4
$163K Hold
710
0.01% 432
2021
Q3
$165K Hold
710
0.01% 399
2021
Q2
$137K Buy
+710
New +$141K 0.01% 401

Other funds holding INSP

Clearstead Advisors's INSP Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Inspire Medical Systems (INSP) in Q2 2026: 224 shares worth $9.99K. The stake represents ﹤0.01% of the portfolio and ranks #1974 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in INSP as recently as Q4 2025.

Clearstead Advisors first reported a position in INSP in Q2 2021 and has held it in 19 quarters since. The position peaked at $344K in Q3 2023. 105 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Clearstead Advisors held 224 shares of Inspire Medical Systems worth $9.99K as of Q2 2026.
  • Inspire Medical Systems was a new Clearstead Advisors position in Q2 2026.
  • Inspire Medical Systems made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1974 holding.
  • Clearstead Advisors first reported a position in Inspire Medical Systems in Q2 2021 and has held it in 19 quarters since.
  • Clearstead Advisors's Inspire Medical Systems position peaked at $344K in Q3 2023.
  • 105 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.